Most recent by Bobby Azamian, MD, PhD
SPONSORED CONTENT
June 29, 2022
2 min watch
Save
VIDEO: Tarsus CEO shares takeaways on physician entrepreneurship in ophthalmology
NEWPORT BEACH, Calif. — In this Healio Video Perspective at the Octane Ophthalmology Technology Summit, Bobak Azamian, MD, PhD, CEO and co-founder of Tarsus Pharmaceuticals, discusses ophthalmic entrepreneurship.
SPONSORED CONTENT
May 02, 2022
3 min watch
Save
VIDEO: Tarsus announces positive phase 3 data for TP-03 for Demodex blepharitis
In this Healio Video Perspective, Bobak Azamian, MD, PhD, CEO and co-founder of Tarsus Pharmaceuticals, discusses topline data from the Saturn-2 phase 3 study of TP-03 for the treatment of Demodex blepharitis.
SPONSORED CONTENT
October 09, 2020
4 min watch
Save
VIDEO: Potential Demodex blepharitis treatment moving through trials
In this Healio Video Perspective, Bobby Azamian, MD, PhD, CEO of Tarsus Pharmaceuticals, discusses TP-03, a topical ophthalmic preparation of an established acaricide, which is now in a phase 2b/3 trial.